The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: December 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers

  • 1. Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
  • 2. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis
  • 3. Targeting cancer with small-molecule pan-KRAS degraders
  • 4. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection
  • 5. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
  • 7. ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer
  • 8. Macrophage-mediated myelin recycling fuels brain cancer malignancy
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
  • 10. Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
  • 11.
Previous
Next

Sundaram, L., Kumar, A., Zatzman, M. et al. Science. 385 (6713): eadk9217 (2024).
doi: 10.1126/science.adk9217.

Summary and graphical abstract by Alexandra Boitor, EACR Scientific Officer

Summary of the findings

One of the challenges in cancer research is identifying and understanding the diverse molecular features associated with different genetic lesions and gene regulatory changes that drive carcinogenesis and cancer progression. The Cancer Genome Atlas (TCGA) was created to map diverse molecular features associated with malignancy. One method employed to answer this question has been chromatin accessibility mapping using ATAC-seq, which led to the identification of several malignant signatures across 23 primary human cancer types. However, most studies were performed in bulk cancer tissues, so the current landscape of regulatory elements contains information from tumour-associated stromal or immune cells. In this paper, the authors aimed to deconvolute the existent data from TCGA for eight cancer types (74 individual samples) by employing single-cell chromatin accessibility.
.
The authors managed to successfully separate cancer cells, tumour-infiltrating immune cells and stromal cells based on the single-cell chromatin availability data. Furthermore, the authors were able to identify and measure chromatin accessibility differences in immune cell subsets from various cancer types, cis-regulatory differences between distinct subclones in two samples of glioblastoma and identify the most likely cell type of origin for several breast cancer subtypes. The authors also generated neural network models to predict the impact of genetic variation on chromatin accessibility.
.
.Read more in Science

9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers

  • 1. Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer
  • 2. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis
  • 3. Targeting cancer with small-molecule pan-KRAS degraders
  • 4. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection
  • 5. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
  • 6. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations
  • 7. ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer
  • 8. Macrophage-mediated myelin recycling fuels brain cancer malignancy
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
  • 10. Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
  • 11.
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

VIDEO |  How to get through “failure” in a research career

VIDEO | How to get through “failure” in a research career

October 16, 2025

Click above to watch At the Early Career Researchers’ Conference 2025, we enjoyed a brilliant programme of diverse sessions from a range of experts, including Joan...

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

July 16, 2025

Dr. Alexandra Boitor, EACR Scientific Officer, gives a few of the highlights from Cancer Researchers to Watch: An early career showcase (Lisbon, 15-16 June 2025). The EACR's...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: July 2025

October 17, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast
Podcast

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast

November 7, 2025
“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship
Community

“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship

November 5, 2025
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

Table of Contents

×
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
    • Summary of the findings
  • 9. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
→ Table of Contents
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR